Jefferies Financial Group Has Lowered Expectations for Danaher (NYSE:DHR) Stock Price

Danaher (NYSE:DHR) had its price objective decreased by stock analysts at Jefferies Financial Group from $265.00 to $240.00 in a research report issued on Wednesday,MarketScreener reports. The brokerage presently has a “buy” rating on the conglomerate’s stock. Jefferies Financial Group’s price objective would indicate a potential upside of 22.07% from the stock’s current price.

DHR has been the topic of several other reports. Leerink Partners increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Evercore cut their price objective on shares of Danaher from $254.00 to $225.00 and set an “outperform” rating on the stock in a report on Monday. The Goldman Sachs Group cut their price objective on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 29th. Wells Fargo & Company increased their price objective on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $251.35.

Danaher Price Performance

Shares of DHR stock traded up $5.61 during trading hours on Wednesday, reaching $196.62. 163,691 shares of the company were exchanged, compared to its average volume of 4,015,473. Danaher has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The stock’s fifty day moving average is $202.70 and its two-hundred day moving average is $214.59. The company has a market cap of $139.14 billion, a price-to-earnings ratio of 38.90, a P/E/G ratio of 2.59 and a beta of 0.95. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same period in the prior year, the business earned $2.14 earnings per share. Danaher’s quarterly revenue was up 4.6% on a year-over-year basis. Sell-side analysts forecast that Danaher will post 7.63 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.20% of the company’s stock.

Institutional Investors Weigh In On Danaher

Several large investors have recently bought and sold shares of DHR. JPL Wealth Management LLC bought a new stake in Danaher in the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC bought a new stake in shares of Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the second quarter worth $26,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher during the third quarter worth $27,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the fourth quarter worth $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.